Is GRAIL (Ticker: GRAL) with its Galleri Cancer test ready for Prime Time?
Vložit
- čas přidán 19. 07. 2024
- Greetings, fellow investors! Welcome back to ShareTreck. I'm Raj, today I am going to share my thoughts around Grail which was recently spun off from Illumina. It has a great blood test for Cancer but is it ready for PrimeTime?
Well this is my personal opinion, not financial advice.
JOIN THE CHANNEL AS A MEMBER:
Please check out the membership offering and join me in the exciting new chapter for ShareTreck, Thanks for your support so far and looking forward to much more. Use the link below to join or click on the Join button on the bottom left of your screen or copy the link below to your browser address bar and press enter.
/ @sharetreck
Please subscribe: / @sharetreck
The videos in this channel should not be construed as financial advice. Always make sure to do your own due diligence and research.
Please do not trade or invest based on this video. Information provided in this video is not investment advice and is for entertainment purposes only.
In case of coverage of pharma companies, disease and therapy details are derived from news articles and publications by companies or research organizations. I am not a doctor but am only facilitating dissemination of published information. - Zábava
it's GRAIL time!
nice background music
tho at the beginning it was a bit louder than our voice raj
what a fumble by Illumina eh
grail however - I am looking forward to reading those earnings when they come out for grails
anti trust issues make me alarmed tho
I have always had problem mixing background audio. I keep it very low but results on other devices are unpredictable. I will stop intro music for now until we fix this issue.